• Precision PERK Inhibition: GSK2606414’s Impact on ER Stress

  2026-06-15

  Discover how GSK2606414, a selective PERK inhibitor from APExBIO, is transforming ER stress research by unraveling the mechanistic links between ER homeostasis, cell fate, and inflammation. This thought-leadership article bridges fundamental insights—like the PERK/JAK1–STAT3 axis’s role in disc degeneration—with translational strategies for disease modeling, assay design, and therapeutic targeting across oncology and neurodegenerative disease.

• Isoprinosine in Antiviral Immunotherapy: Deep Mechanistic In

  2026-06-14

  Explore the advanced immunomodulatory mechanisms of Isoprinosine (inosine pranobex) in viral infection models. This article reveals new assay strategies and practical guidance grounded in recent herpesvirus egress breakthroughs.

• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-06-13

  The AO/PI Double Staining Kit enables rapid, differential identification of viable, apoptotic, and necrotic cells through dual fluorescent staining. It is best used for direct cell viability, apoptosis, and necrosis detection in various cell types. This kit is not intended for tissue section analysis or applications outside the scope of fluorescent cell staining workflows.

• Elobixibat Hydrate: Optimizing Ileal Bile Acid Transporter I

  2026-06-12

  Elobixibat hydrate empowers translational GI and metabolic research with best-in-class selectivity and reproducibility. This guide details stepwise workflows, advanced applications, and troubleshooting strategies to maximize experimental reliability and data quality with this selective ileal bile acid transporter inhibitor.

• Simvastatin (Zocor): Protocol Innovations in Lipid and Cance

  2026-06-12

  Simvastatin (Zocor) from APExBIO is uniquely positioned for both cholesterol metabolism and apoptosis induction workflows, enabling precise investigation of lipid disorders and cancer cell fate. This guide translates the latest lipidomics and oncology research into actionable protocols, troubleshooting, and advanced applications for bench scientists.

• CTOP and Central Pathways: Redefining Opioid Mechanism Resea

  2026-06-11

  Amidst the opioid crisis and the clinical challenge of opioid-induced hypersensitivity and tolerance, translational researchers increasingly need tools and frameworks to dissect central and peripheral μ-opioid receptor mechanisms. This article provides mechanistic insights into the central regulation of opioid responses, strategic advice for designing robust opioid receptor binding studies, and a forward-looking perspective on how CTOP—an APExBIO flagship μ-opioid receptor antagonist—can help unlock the next generation of pain research breakthroughs.

• MHY1485: Advancing mTOR Pathway Research Beyond Autophagy As

  2026-06-11

  Explore how MHY1485, a potent mTOR activator, is revolutionizing experimental design in cell metabolism, autophagy, and ovarian follicle development research. This article uniquely bridges protocol optimization and translational insight for advanced mTOR signaling studies.

• Moxidectin: Macrocyclic Lactone Anthelmintic in Antifungal S

  2026-06-10

  Moxidectin, a macrocyclic lactone anthelmintic, is redefining translational research by enhancing polyene antifungal efficacy against Candida albicans. This article decodes stepwise workflows, key innovations, and troubleshooting strategies for leveraging APExBIO's high-purity Moxidectin in both veterinary and emerging antifungal applications.

• Mutant-Specific p53 Reactivation via Chemically Induced Prox

  2026-06-10

  This study introduces TRAP-1, a small molecule that specifically activates the cancer-associated p53Y220C mutant by inducing its proximity to BRD4, restoring transcriptional activity and tumor suppressor function. The approach demonstrates a novel paradigm for reactivating mutant p53 proteins in cancer, with significant implications for targeted therapeutic development.

• Protease and Phosphatase Inhibitor Cocktail: Precision in Pr

  2026-06-09

  Unlock uncompromising preservation of protein integrity and phosphorylation with the Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O). This solution from APExBIO ensures reproducibility and specificity for complex lysates, empowering advanced signaling and post-translational modification research.

• Astrocytic GAT-3 Controls Synaptic Transmission in Dentate G

  2026-06-09

  This study reveals that GAT-3 in astrocytes regulates synaptic transmission and memory formation in the dentate gyrus through modulation of astrocytic calcium signaling. The findings highlight a critical astrocyte-mediated pathway in hippocampal cognitive processing, opening new directions for targeted approaches in synaptic transmission research.

• PF-04971729 (Ertugliflozin): Advancing SGLT2 Inhibitor Resea

  2026-06-08

  PF-04971729 (Ertugliflozin) stands out as a precision tool for dissecting renal glucose transport and cardiometabolic outcomes in translational diabetes research. Explore actionable protocols, troubleshooting insights, and comparative advantages that set this selective SGLT2 inhibitor apart for high-fidelity experimentation.

• Fluorescein TSA Fluorescence System Kit: Amplifying IHC Sens

  2026-06-08

  The Fluorescein TSA Fluorescence System Kit delivers high-sensitivity detection of low-abundance biomolecules, revolutionizing immunohistochemistry, immunocytochemistry, and in situ hybridization workflows. With tyramide signal amplification, this kit empowers researchers to overcome detection limits and achieve crisp, localized fluorescence in fixed tissue and cell samples.

• Metformin Hydrochloride: Expanding Horizons in Tendon Ossifi

  2026-06-07

  Explore the multifaceted research applications of Metformin Hydrochloride (Metformin HCl), including its unique modulation of tendon ossification and glucose metabolism. This in-depth analysis highlights advanced mechanisms and practical considerations for biomedical studies.

• Proteoform-Specific Interactions: Insights from Native MS Dr

  2026-06-06

  This article examines a Nature Chemistry study that pioneers the direct analysis of proteoform-specific interactions in native cell signalling environments using advanced mass spectrometry. The findings reveal how post-translational modifications and alternative splicing shape drug binding profiles, with direct implications for the selectivity and safety of cGMP-specific phosphodiesterase type 5 inhibitors such as Sildenafil Citrate.

555 records 15/37 page Previous Next First page 上5页 1112131415 下5页 Last page